We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 41-60 of 10,000 results
  1. Health and economic burden due to alcohol-associated liver diseases in the Union Territory of Delhi: A Markov probabilistic model approach

    Background

    Nearly one-fifth of all deaths attributable to alcohol are due to liver diseases.

    Methods

    The study employs a Markov Probabilistic Modeling...

    Archana Ramalingam, Samba Siva Rao Pasupuleti, ... Shiv Kumar Sarin in Indian Journal of Gastroenterology
    Article 28 February 2022
  2. Perioperative Management of the Patient with End-Stage Liver Disease

    Purpose of Review

    End-stage liver disease is associated with increased perioperative morbidity and mortality. This narrative review provides a summary...

    Flora Simmons, Tailour Roberson, Adebukola Owolabi in Current Anesthesiology Reports
    Article 06 February 2024
  3. Knowledge needs in patients with Liver Disease: a qualitative study

    Background

    Knowledge is essential for patients’ disease management strategies and a critical component of healthcare. The importance of increasing...

    Birgitte Gade Jacobsen, Mette Munk Lauridsen, Lea Ladegaard Grønkjaer in BMC Nursing
    Article Open access 30 October 2023
  4. Liver stiffness, hepatorenal index, and microRNA-130b as predictors for chronic kidney disease in patients with non-alcoholic fatty liver disease

    Background and aim

    Currently, nonalcoholic liver disease (NAFLD) is the most predominant chronic liver disorder. NAFLD has been linked to hepatic and...

    Mohamed Yosef El Hassafy, Abeer Shawky Elhadidi, ... Sameh Aldesoky Lashen in Egyptian Liver Journal
    Article Open access 15 July 2023
  5. Portal Hypertension in Alcohol-Associated Hepatitis

    Purpose of Review

    This review article will examine portal hypertension in alcoholic hepatitis (AH) from both a basic mechanistic and a clinical...

    Matthew J. McConnell, Yasuko Iwakiri in Current Hepatology Reports
    Article 05 April 2023
  6. Association of metabolic dysfunction-associated fatty liver disease with kidney disease

    Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in more than 5% of hepatocytes in the absence of excessive...

    Ting-Yao Wang, Rui-Fang Wang, ... Ming-Hua Zheng in Nature Reviews Nephrology
    Article 10 January 2022
  7. Multiparametric magnetic resonance imaging of the liver and spleen in Gaucher disease

    Purpose

    To assess liver and spleen characteristics of a population with Gaucher disease (GD) using multiparametric MRI and MR elastography (MRE) for...

    Daniella Braz Parente, Fernanda Chagas Monteiro de Melo Malta, ... Rosana Souza Rodrigues in Abdominal Radiology
    Article 20 April 2024
  8. Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations

    Background and Aim

    Roux-En-Y gastric bypass (RYGB) is associated with risk of alcohol use disorder. The impact of RYGB among patients with...

    Pradeep Yarra, Winston Dunn, ... Ashwani K. Singal in Digestive Diseases and Sciences
    Article 04 July 2022
  9. Towards precision medicine in non-alcoholic fatty liver disease

    Non-Alcoholic Fatty Liver Disease (NAFLD) refers to the accumulation of lipid laden vacuoles in hepatocytes, occurring in the context of visceral...

    Article 21 July 2023
  10. Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population

    Background

    Non-alcoholic fatty liver disease (NAFLD) is a growing public health concern. Modifiable factors such as diet and lifestyle are of research...

    Yurou Xu, Youyi Wang, ... **ng Liu in Hepatology International
    Article 26 February 2024
  11. Patients undergoing liver resection for non-alcoholic fatty liver disease-related hepatocellular carcinoma and those for viral hepatitis-related hepatocellular carcinoma have similar survival outcomes

    Numerous studies have compared outcomes of liver resection (LR) of patients with non-alcoholic fatty liver disease (NAFLD)-related hepatocellular...

    Yi-Hao Yen, Fang-Ying Kuo, ... Chih-Yun Lin in Updates in Surgery
    Article 07 April 2024
  12. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications

    Background/purpose

    A nomenclature of “metabolic associated fatty liver disease” (MAFLD) with a new definition was proposed in 2020 instead of the...

    Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao in Hepatology International
    Article 05 December 2022
  13. The Association Between Periodontal Disease and Non-Alcoholic Fatty Liver Disease is Linked to Metabolic Disorders

    Purpose of Review

    Non-alcoholic fatty liver disease (NAFLD) is recognized as the most common cause of chronic liver disease. NAFLD regularly coexists...

    Yuto Kusu, Michiko Furuta, Toru Takeshita in Current Oral Health Reports
    Article 11 August 2023
  14. Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease

    Recompensation has gained increasing attention in the field of cirrhosis, particularly in chronic liver disease with a definite aetiology. The...

    Gong Feng, Luca Valenti, ... Ming-Hua Zheng in Nature Reviews Gastroenterology & Hepatology
    Article 05 October 2023
  15. Insulin Resistance/Sensitivity Measures as Screening Indicators of Metabolic-Associated Fatty Liver Disease and Liver Fibrosis

    Background

    Measures of insulin resistance (IR)/sensitivity (IS) are emerging tools to identify metabolic-associated fatty liver disease (MAFLD)....

    Mohammad E. Khamseh, Mojtaba Malek, ... Fariba Alaei-Shahmiri in Digestive Diseases and Sciences
    Article 04 March 2024
  16. Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective

    Introduction

    The prevalence, health and socioeconomic burden of metabolic dysfunction-associated fatty liver disease (MAFLD) is growing, increasing...

    Shelley E. Keating, Yogesh Chawla, ... Elena S. George in Hepatology International
    Article Open access 08 May 2024
  17. Harnessing the Proteostasis Network in Alcohol-associated Liver Disease

    Purpose of Review

    Alcohol-associated liver disease (ALD) accounts for significant mortality and morbidity in the USA. Prolonged alcohol exposure leads...

    Asmita Choudhury, Pranoti Mandrekar in Current Pathobiology Reports
    Article 17 July 2020
  18. The Role of Micronutrients in Chronic Liver Disease

    Purpose of Review

    The importance of general nutrition in chronic liver disease is well established. The role of this review is to identify and...

    Bassem Ibrahim, Dhanashree Tikhe, Steven Bollipo in Current Hepatology Reports
    Article 22 June 2023
  19. Factors associated with public awareness of the relationship between alcohol use and breast cancer risk

    Background

    Public awareness of the carcinogenic effects of alcohol is low, particularly the association between alcohol use and the risk of develo**...

    Anne Doyle, Claire O’Dwyer, ... Brian Galvin in BMC Public Health
    Article Open access 28 March 2023
  20. Metabolic dysfunction-associated steatotic liver disease and atherosclerosis

    Purpose of review

    To update information about the relationship between metabolic dysfunction-associated steatotic liver disease (MASLD) and...

    Yulino Castillo-Núñez, Paloma Almeda-Valdes, ... María del Rosario Arechavaleta-Granell in Current Diabetes Reports
    Article 03 May 2024
Did you find what you were looking for? Share feedback.